NM_001243540.2:c.-99+151G>T
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001243540.2(CEP295NL):c.-99+151G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.514 in 152,090 control chromosomes in the GnomAD database, including 20,937 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.51   (  20937   hom.,  cov: 33) 
Consequence
 CEP295NL
NM_001243540.2 intron
NM_001243540.2 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  -1.05  
Publications
12 publications found 
Genes affected
 CEP295NL  (HGNC:44659):  (CEP295 N-terminal like) Predicted to enable microtubule binding activity. Predicted to be involved in regulation of centriole replication. Predicted to be located in motile cilium. Predicted to be active in centriole; centrosome; and cytosol. [provided by Alliance of Genome Resources, Apr 2022] 
 TIMP2  (HGNC:11821):  (TIMP metallopeptidase inhibitor 2) This gene is a member of the TIMP gene family. The proteins encoded by this gene family are natural inhibitors of the matrix metalloproteinases, a group of peptidases involved in degradation of the extracellular matrix. In addition to an inhibitory role against metalloproteinases, the encoded protein has a unique role among TIMP family members in its ability to directly suppress the proliferation of endothelial cells. As a result, the encoded protein may be critical to the maintenance of tissue homeostasis by suppressing the proliferation of quiescent tissues in response to angiogenic factors, and by inhibiting protease activity in tissues undergoing remodelling of the extracellular matrix. [provided by RefSeq, Jul 2008] 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94). 
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.703  is higher than 0.05. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| CEP295NL | NM_001243540.2 | c.-99+151G>T | intron_variant | Intron 1 of 2 | ENST00000322630.3 | NP_001230469.1 | ||
| TIMP2 | NM_003255.5 | c.130+21976G>T | intron_variant | Intron 1 of 4 | ENST00000262768.11 | NP_003246.1 | 
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| CEP295NL | ENST00000322630.3 | c.-99+151G>T | intron_variant | Intron 1 of 2 | 2 | NM_001243540.2 | ENSP00000312767.2 | |||
| TIMP2 | ENST00000262768.11 | c.130+21976G>T | intron_variant | Intron 1 of 4 | 1 | NM_003255.5 | ENSP00000262768.6 | 
Frequencies
GnomAD3 genomes  0.514  AC: 78164AN: 151972Hom.:  20925  Cov.: 33 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
78164
AN: 
151972
Hom.: 
Cov.: 
33
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome  0.514  AC: 78210AN: 152090Hom.:  20937  Cov.: 33 AF XY:  0.511  AC XY: 38022AN XY: 74358 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
78210
AN: 
152090
Hom.: 
Cov.: 
33
 AF XY: 
AC XY: 
38022
AN XY: 
74358
show subpopulations 
African (AFR) 
 AF: 
AC: 
15026
AN: 
41482
American (AMR) 
 AF: 
AC: 
8820
AN: 
15286
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
1898
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
3727
AN: 
5156
South Asian (SAS) 
 AF: 
AC: 
2853
AN: 
4818
European-Finnish (FIN) 
 AF: 
AC: 
5026
AN: 
10590
Middle Eastern (MID) 
 AF: 
AC: 
150
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
39028
AN: 
67968
Other (OTH) 
 AF: 
AC: 
1112
AN: 
2112
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.499 
Heterozygous variant carriers
 0 
 1914 
 3828 
 5741 
 7655 
 9569 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 702 
 1404 
 2106 
 2808 
 3510 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
2257
AN: 
3478
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.